T-cell lymphoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
'''For patient information click [[{{PAGENAME}} (patient information)|here]]'''. | '''For patient information click [[{{PAGENAME}} (patient information)|here]]'''. | ||
{{CMG}} {{AE}} | {{CMG}}; {{AE}}{{Anmol}} | ||
{{T cell lymphoma}} | {{T cell lymphoma}} | ||
| Line 11: | Line 12: | ||
==Classification== | ==Classification== | ||
T-cell lymphomas may be classified according to updated WHO classification into 2 subtypes: | T-cell lymphomas may be classified according to updated WHO classification into 2 subtypes:<ref name="pmid26980727">{{cite journal |vauthors=Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES |title=The 2016 revision of the World Health Organization classification of lymphoid neoplasms |journal=Blood |volume=127 |issue=20 |pages=2375–90 |date=May 2016 |pmid=26980727 |pmc=4874220 |doi=10.1182/blood-2016-01-643569 |url=}}</ref> | ||
{| style="border: 0px; font-size: 90%; margin: 3px;" align="center" | |||
|+'''Updated WHO classification of Non-Hodgkin lymphoma''' | |||
! style="background: #4479BA; color:#FFF; text-align: center; font-weight: bold;" |T-cell and putative NK-cell neoplasms | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; text-align: center;" |'''Precursor T-cell neoplasm''' | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |Precursor T-acute lymphoblastic leukemia / [[lymphoblastic lymphoma]] (LBL) | |||
|- | |||
| style="padding: 5px 5px; background: #DCDCDC; text-align: center; font-weight: bold;" |Peripheral T-cell and NK-cell neoplasms | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |[[T-cell prolymphocytic leukemia]] | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |[[T-cell granular lymphocytic leukemia]] | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |[[Chronic lymphoproliferative disorder of NK cells]] | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |[[Aggressive NK-cell leukemia]] | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |Systemic EBV positive T-cell lymphoma of childhood | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |Hydroa vacciniforme like lymphoproliferative disorder | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |[[Adult T-cell leukemia/lymphoma]] | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |Extranodal T/NK-cell lymphoma, nasal type | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |[[Enteropathy-type intestinal T-cell lymphoma|Enteropathy associated intestinal T-cell lymphoma]] | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |Monomorphic epitheliotropic intestinal T-cell lymphoma | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |Indolent T-cell lymphoproliferative disorder of the GI tract | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |[[Hepatosplenic T cell lymphoma|Hepatosplenic T-cell lymphoma]] | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |[[Subcutaneous panniculitis-like T-cell lymphoma]] | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |[[Mycosis fungoides]] | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |[[Sézary syndrome]] | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |Primary cutaneous CD30 T-cell lymphoproliferative disorders | |||
*Lymphomatoid papulosis | |||
*Primary cutaneous anaplastic large cell lymphoma | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |Primary cutaneous gamma delta T-cell lymphoma | |||
Primary cutaneous CD8 aggressive epidermotropic cytotoxic T-cell lymphoma | |||
Primary cutaneous acral CD8 T-cell lymphoma | |||
Primary cutaneous CD4 small/medium T-cell lymphoproliferative disorder | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |Peripheral T-cell lymphoma, NOS * | |||
[[Peripheral T-cell lymphoma]], not otherwise characterized | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |[[Angioimmunoblastic T-cell lymphoma]] | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |Follicular T-cell lymphoma | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |Nodal peripheral T-cell lymphoma with TFH phenotype | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |[[Anaplastic large cell lymphoma]] | |||
*ALK positive | |||
*ALK negitive | |||
|- | |||
| style="padding: 5px 5px; background: #F5F5F5; text-align: left;" |Breast implant associated anaplastic large-cell lymphoma | |||
|} | |||
Revision as of 18:14, 15 February 2019
For patient information click here.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Anmol Pitliya, M.B.B.S. M.D.[2]
Overview
T-cell lymphoma describes several different types of Non-Hodgkin lymphoma affecting T cells or Natural killer cells (NK-cells), also knownas a NK/T-cell lymphoma. Any organ that has lymphatic tissue may develop a lymphoma, including the spleen, thymus, adenoids, tonsils, digestive tract and bone marrow. Characteristically, they may present as fast (aggressive) or slow (indolent) growing lymphomas.
Lymphomas are named after the precursor cell from which it developed. A peripheral T-cell lymphomas include lymphomas which arise from mature T-cells (after maturation in the thymus), in contrast with immature T-cell lymphomas, the lymphoblastic lymphoma.
Classification
T-cell lymphomas may be classified according to updated WHO classification into 2 subtypes:[1]
| T-cell and putative NK-cell neoplasms |
|---|
| Precursor T-cell neoplasm |
| Precursor T-acute lymphoblastic leukemia / lymphoblastic lymphoma (LBL) |
| Peripheral T-cell and NK-cell neoplasms |
| T-cell prolymphocytic leukemia |
| T-cell granular lymphocytic leukemia |
| Chronic lymphoproliferative disorder of NK cells |
| Aggressive NK-cell leukemia |
| Systemic EBV positive T-cell lymphoma of childhood |
| Hydroa vacciniforme like lymphoproliferative disorder |
| Adult T-cell leukemia/lymphoma |
| Extranodal T/NK-cell lymphoma, nasal type |
| Enteropathy associated intestinal T-cell lymphoma |
| Monomorphic epitheliotropic intestinal T-cell lymphoma |
| Indolent T-cell lymphoproliferative disorder of the GI tract |
| Hepatosplenic T-cell lymphoma |
| Subcutaneous panniculitis-like T-cell lymphoma |
| Mycosis fungoides |
| Sézary syndrome |
Primary cutaneous CD30 T-cell lymphoproliferative disorders
|
| Primary cutaneous gamma delta T-cell lymphoma
Primary cutaneous CD8 aggressive epidermotropic cytotoxic T-cell lymphoma Primary cutaneous acral CD8 T-cell lymphoma Primary cutaneous CD4 small/medium T-cell lymphoproliferative disorder |
| Peripheral T-cell lymphoma, NOS *
Peripheral T-cell lymphoma, not otherwise characterized |
| Angioimmunoblastic T-cell lymphoma |
| Follicular T-cell lymphoma |
| Nodal peripheral T-cell lymphoma with TFH phenotype |
Anaplastic large cell lymphoma
|
| Breast implant associated anaplastic large-cell lymphoma |
- ↑ Swerdlow SH, Campo E, Pileri SA, Harris NL, Stein H, Siebert R, Advani R, Ghielmini M, Salles GA, Zelenetz AD, Jaffe ES (May 2016). "The 2016 revision of the World Health Organization classification of lymphoid neoplasms". Blood. 127 (20): 2375–90. doi:10.1182/blood-2016-01-643569. PMC 4874220. PMID 26980727.